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Abstract objective To compare the impact of malaria rapid diagnostic tests (mRDTs), used by community
health workers (CHWs), on the proportion of children <5 years of age receiving appropriately
targeted treatment with artemisinin-based combination therapy (ACT), vs. presumptive treatment.
methods Cluster-randomized trials were conducted in two contrasting areas of moderate-to-high
and low malaria transmission in rural Uganda. Each trial examined the effectiveness of mRDTs in the
management of malaria and targeting of ACTs by CHWs comparing two diagnostic approaches: (i)
presumptive clinical diagnosis of malaria [control arm] and (ii) confirmatory diagnosis with mRDTs
followed by ACT treatment for positive patients [intervention arm], with village as the unit of
randomisation. Treatment decisions by CHWs were validated by microscopy on a reference blood
slide collected at the time of consultation, to compare the proportion of children <5 years receiving
appropriately targeted ACT treatment, defined as patients with microscopically-confirmed presence of
parasites in a peripheral blood smear receiving artemether-lumefantrine or rectal artesunate, and
patients with no malaria parasites not given ACT.
results In the moderate-to-high transmission area, ACT treatment was appropriately targeted in
79.3% (520/656) of children seen by CHWs using mRDTs to diagnose malaria, vs. 30.8% (215/699)
of children seen by CHWs using presumptive diagnosis (P < 0.001). In the low transmission area,
90.1% (363/403) children seen by CHWs using mRDTs received appropriately targeted ACT treatment
vs. 7.8% (64/817) seen by CHWs using presumptive diagnosis (P < 0.001). Low mRDT sensitivity in
children with low-density parasitaemia (<200 parasites/ll) was identified as a potential concern.
conclusion When equipped with mRDTs, ACT treatments delivered by CHWs are more accurately
targeted to children with malaria parasites. mRDT use could play an important role in reducing
overdiagnosis of malaria and improving fever case management within iCCM, in both moderate-to-
high and low transmission areas. Nonetheless, missed treatments due to the low sensitivity of current
mRDTs in patients with low parasite density are a concern. For community-based treatment in areas
of low transmission and/or non-immune populations, presumptive treatment of all fevers as malaria
may be advisable, until more sensitive diagnostic assays, suitable for routine use by CHWs in remote
settings, become available.
keywords Rapid diagnostic test (RDT), artemisinin-based combination therapy (ACT), community
health workers (CHWs), appropriately targeted treatment, Uganda, community case management
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Introduction
Early diagnosis and effective case management is a cen-
tral component of the current malaria control strategy [1,
2], yet millions live at or beyond the periphery of the
health system. Improving access to care for childhood
infectious diseases by bringing treatment closer to the
community is an attractive option, especially in rural set-
tings where distance, cost and infrastructural challenges
of primary healthcare centres limit access to expert ser-
vices [3]. Targeting artemisinin-based combination ther-
apy (ACT) to those who are parasitologically confirmed
malaria cases is critical in reducing misdiagnosis and
overuse of these expensive drugs and may play an impor-
tant role in the financial sustainability of community-
based programmes [4–6]. The World Health Organiza-
tion (WHO) now recommends universal access to malaria
diagnostics [7], and at the moment, antigen-based rapid
diagnostic tests (mRDTs) are the only feasible test at
community level. The case for their use rather than pre-
sumptive treatment is strong, due to lack of accurate
algorithm-based diagnosis [8] and negative consequences
of overuse of antimalarials [6]. Although there is evidence
that mRDTs and ACTs can be successfully deployed at
community level [9, 10], there is little information on
whether their use improves the targeting of ACTs to
malaria patients at that level, especially in low transmis-
sion settings. We conducted a cluster-randomized con-
trolled trial to compare the impact of mRDTs, used by
CHWs, on the proportion of children <5 years of age
receiving appropriately targeted treatment with ACT, vs.
presumptive treatment. The study took place in two dif-
ferent malaria transmission settings in rural Uganda to
provide evidence to optimise use of ACTs and mRDTs
within programmes of integrated community case man-
agement (iCCM) that are currently being scaled up in
Uganda and other countries.
Materials and methods
Study area
The study was conducted in Rukungiri District, south-
western Uganda, inhabited by the Bahororo and Bakiga
ethnic groups, whose main occupation is subsistence
farming. Anaemia among under-fives in south-western
Uganda is estimated at 40%, and in other regions of the
country, it ranges from 57% to 74% [11]. The district
was selected for the study due to its wide altitudinal
range between 980 and 2160 m above sea level, resulting
in diverse malaria transmission patterns within the same
district. Two subcounties with contrasting malaria trans-
mission were selected as trial sites: Bwambara subcounty,
a lower altitudinal area bordered by Lake Edward, which
is meso-endemic for malaria with moderate-to-high trans-
mission, and Nyakishenyi subcounty, an epidemic-prone
highland area with low transmission, which is hypo-ende-
mic for malaria.
All villages in the two subcounties were invited to par-
ticipate in the trial: 63 villages in Bwambara, ranging
between 981–1203 m, and 64 villages in Nyakishenyi,
ranging between 1064–2157 m. A public meeting was
held in each eligible community to explain the purpose of
the research, and community members were asked to
identify 2–3 CHWs per village for training. Written
informed consent to take part in the trial was sought
from community leaders and all CHWs selected for train-
ing, of whom more than 50% had previously worked in
the home-based management of fever (HBMF) pro-
gramme that was defunct at the time of the study.
Trial design
A cluster-randomized two-arm trial design was used to
compare the effectiveness of mRDTs used by CHWs to
diagnose and treat malaria with ACT [intervention] to
presumptive diagnosis and treatment of malaria with
ACT [control]. The unit of randomisation was the vil-
lage, with all CHWs in the same village receiving the
same type of training. Within each transmission area
(subcounty), villages were randomly allocated, using a
random number table in Epi Info, to either the interven-
tion (mRDT) or control (presumptive treatment) arm.
Community health workers in both arms of the trial
were trained in recognising signs and symptoms of
malaria, how to administer antimalarial treatment and
when to refer (Figure 1, Table 1). Half of the villages
were randomized to receive additional training in
malaria diagnosis using mRDTs (intervention villages)
and trained to only give antimalarial treatment with
ACT after a positive test result, with the aim to increase
the proportion of children receiving appropriately
targeted treatment.
Intervention
Participatory training workshops in malaria case manage-
ment were held for CHWs in each arm, based on a trai-
ner’s manual and accompanying set of pictorial job aids
(available from www.actconsortium.org/RDThomeman
agement). Training workshops lasted 3 days for CHWs
in the control arm and 4 days for CHWs in the mRDT
intervention arm. The latter received an additional 1-day
training to cover the rationale for diagnostic testing in
febrile patients, performing an mRDT and interpretation
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of the test result based on training materials from WHO
[12]. CHWs in the intervention arm were trained to treat
children with a mRDT-positive test and symptoms of
uncomplicated malaria with artemether–lumefantrine;
and to treat mRDT-positive children with danger signs
with rectal artesunate as a pre-referral treatment, and
refer these children to the nearest health unit. CHWs
were also trained to refer mRDT-negative children if the
child either had danger signs or other specific symptoms
where examination and treatment at a health facility
would be beneficial.
Community health workers in the control villages
were trained to either dispense artemether–
lumefantrine or rectal artesunate based on presumptive
diagnosis of malaria, according to signs and symp-
toms. The training, support materials and procedures
were identical in every respect except for the method
of diagnosis to be used. In both arms, CHWs were
trained in signs for referral (Box 1), completion of
treatment records, stock management and preparation
of blood slides for reference microscopy. Training
encouraged interactive discussion and reflective prac-
tice, supported by role-play to practice communication
skills necessary to obtain clinical history and explain
outcome of diagnosis, treatment given and referral
advice.
Health facility
CHW
Community
Diagnosis and treatment
by CHWs
Community 
engagement: 
Selection of CMDs
Training of CHWs 
(Patient communication 
skills & role-play)
Close support
supervision
Sensitisation to 
change in 
diagnostic policy
Severe 
malaria
Rectal artesunate
and REFER
RDT-negative 
fever 
RDT-positive
malaria
ACT
No ACT 
and refer
CHW Training
(Technical skills)
Figure 1 Design of an intervention to
support use of malaria diagnostic tests
(mRDTs) by community health workers
in Uganda.
Table 1 Training and supporting interventions for community health workers in the intervention and control arms
Control arm Intervention arm
3- to 4-day training workshop
Reasons for policy change to mRDT testing before malaria treatment U
How to perform and interpret a mRDT U
What to do for patients with a negative mRDT result U
How to treat a child with malaria U U
How to recognise and treat a child with signs of severe illness, and when to refer U U
How to recognise a child with fevers caused by other illnesses, and when to refer U U
Role-play and communication skills U U
Supporting interventions for trained CHWs
Training certificate with Ministry of Health logo U U
ACTs: age-appropriate pre-packed blister packs with pictorial labelling U U
Pictorial job aids U U
Close support supervision after training – for first 6 months only U U
Bicycle, T-shirt, monthly kerosene allowance and soap U U
Supporting interventions in the community
Community-directed selection of CHWs by popular vote U U
Community sensitisation about mRDTs (community meetings, churches, women’s groups) U U
© 2016 The Authors. Tropical Medicine & International Health Published by John Wiley & Sons Ltd. 1159
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Supporting interventions
Recognising that CHWs may need to broker the change
in diagnostic practice with communities, the training
included practice in communication skills necessary to
explain the rationale for diagnostic testing, result of the
mRDT test and treatments given. In addition, community
sensitisation on diagnostic testing for malaria was carried
out throughout the study area prior to the trial (including
communities in both arms). The key messages were that
not all fevers are malaria and hence a diagnostic test was
advisable before treatment with ACT; and a quick test
(mRDT) could test for malaria, and these tests were
available from government health facilities and trained
CHWs in the intervention villages.
For the first 6 months of implementation (July–
December 2010), CHWs in both arms received addi-
tional close support supervision by project staff through
parish-level CHW meetings to assist adoption of the
new procedures into everyday practice, to promote accu-
rate and complete record keeping and to give advice on
how to handle difficult situations that could affect
adherence, for example caretakers insisting on treatment
even after a negative RDT result. At the end of the
6 months, supervision was scaled back to periodic con-
tacts when CHWs came to collect their supplies and a
monthly allowance for paraffin and soap intended to
support good hygiene and work in the evening/night
(15 000 Uganda Shilling, approximately 4.50 USD).
CHWs were also provided with pictorial job aids,
training certificates, bicycles and T-shirts at the start of
the programme. Although CHWs in Uganda are volun-
teers, expected to work for free, programmes often pro-
vide small ‘refunds’ or tokens, which are generally
expected as compensation.
Evaluation of outcomes
Data on diagnosis and treatment were recorded prospec-
tively on all children seeking treatment for fever in car-
bon-copy duplicated CHWs’ registers, provided for this
purpose. The treatment register for CHWs in the control
arm was similar to the intervention arm except for data
on mRDT result. CHWs in both arms were trained on
how to prepare a thick blood film for every child with
fever who consulted them, for later microscopy, subject
to verbal assent given by the caretaker accompanying
the child. Treatment decisions made by CHWs were val-
idated by light microscopy on the reference blood slide
collected at the time of consultation, to compare appro-
priate targeting of ACTs between arms over a 12-month
period (January–December 2011). The primary endpoint
was the proportion of febrile children with malaria
receiving appropriately targeted treatment with a first-
line antimalarial, a composite outcome defined as: chil-
dren with microscopically-confirmed presence of para-
sites in a peripheral blood smear (slide positive) who
received either artemether–lumefantrine or rectal arte-
sunate, and febrile children with no malaria parasites
(slide negative) who did not receive either of these two
Box 1 Referral guidelines for community health workers
(a) Danger signs for urgent referral (b) Other signs for referral
Refer using emergency referral form if child shows any
of the following symptoms:
1 Convulsions or fits now or within the past 2 days
2 Coma/loss of consciousness
3 Patient is confused or very sleepy; cannot be woken
4 Extreme weakness – unable to stand or sit without support
5 Very Hot – with temperature of 38.5°C or more
6 Very Cold – with temperature of 35.0°C or less
7 Vomiting everything – cannot keep down food or drink
8 Not able to drink or breastfeed
9 Severe anaemia – very pale palms, fingernails, eyelids
10 Yellow eyes
11 Difficulty in breathing
12 Severe dehydration – sunken eyes, sunken
fontanelle, skin pinch, coated tongue
Refer using ordinary referral form if child shows any
of the following symptoms:
1 Fever that has lasted for more than 7 days
2 Fever with measured temperature of 37°C or
more and a negative malaria test result
3 Vomiting and diarrhoea
4 Blood in faeces or blood in urine
5 Pain when passing urine, or frequent urination
6 Wound or burns
7 Skin abscess
8 Painful swelling or lumps in the skin
9 Ear infection (runny ear or child pulling at ear)
10 Sticky or red eyes
11 Fever in a baby <4 months old
If RDT result is positive If RDT result is positive
Treat child (if older than 2 months) with rectal artesunate
suppository prior to referral.
Treat child (if older than 4 months) with
artemether–lumefantine tablets prior to referral.
1160 © 2016 The Authors. Tropical Medicine & International Health Published by John Wiley & Sons Ltd.
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artemisin-based treatments (denominator: all consulta-
tions for fever or history of fever). The other co-primary
outcome was prompt effective treatment defined as the
proportion of febrile children who received appropri-
ately targeted ACT treatment from a CHW within 24 h
of onset of malaria symptoms, while the secondary out-
come was over-prescription defined as the proportion of
children not parasite-positive (slide negative) who
received inappropriate ACT treatment from CHW (de-
nominator: all children with a negative research slide).
Sample size estimation
Based on an observed prevalence of malaria of 50% and
inter-cluster variation k = 0.35 in the moderate-to-high
transmission area during the period of close support super-
vision, a minimum sample size of 6 patients per cluster
(180 patients per arm) was required to demonstrate a 50%
increase in appropriately targeted treatment with use of
mRDTs from 50% to 75%, with 90% power at the 5%
significance level, in a cluster-randomised trial with 30
clusters per arm. The equivalent sample size in the low
transmission area, with 30% malaria prevalence, 32 clus-
ters per arm and inter-cluster variation k = 0.45, to
demonstrate an increase from 30% to 65% was 2 patients
per cluster (128 patients per arm). Taking into account the
lower proportion of cases seeking treatment within 24 h
of onset of symptoms (89% and 83% in each site), sample
size requirements to detect a comparable increase in
prompt appropriately targeted treatment were 9 patients
and 3 patients per cluster (270 and 192 per arm), in the
high-to-moderate and low transmission areas respectively.
Laboratory methods
A finger-prick blood sample was collected by the CHW
at the time of consultation, a thick blood film for micro-
scopy prepared, and mRDT (First Response Ag. P. falci-
parum (HRP2) Card test, www.PremierMedCorp.com;
intervention arm only) performed. The mRDTs passed
independent quality-assurance batch testing by WHO-
FIND, Institut Pasteur, Cambodia. Thick blood smears
were haemolysed and stained with 10% Giemsa for
10 min and examined under light microscopy with oil
immersion objective lens (9100). Asexual parasites were
counted against 200 white blood cells and parasite densi-
ties calculated assuming a standard white blood cell
count of 8000/ll blood. A blood smear was declared neg-
ative if no parasites were detected in 100 high power
fields. Reference slides included in the analysis of the pri-
mary endpoint were subjected to two independent read-
ings by light microscopy. The second reading was
performed by experienced technicians at Vector Control
Division, Ministry of Health in Kampala, blinded to ini-
tial results. Any discrepant results between the first and
second readings were resolved by a third technician
blinded to all previous results. As the number of consul-
tations in Bwambara (moderate-to-high transmission
area) exceeded the sample size requirements, a subsample
of blood slides was randomly selected for analysis of the
primary endpoint. To reflect seasonal variation in the
prevalence of malaria, two slides were randomly sampled
per month from each village during the main evaluation
period from January to December 2011 for double read-
ing (a total of 24 slides per cluster). Malaria was less
common in Nyakashenyi, with fewer consultations, and
thus, all available slides were re-examined by expert
microscopy.
Statistical methods
Data were analysed as intention-to-treat, with analysis
conducted separately for each transmission setting. Due
to the withdrawal of some clusters from the study after
randomisation in the moderate-to-high transmission set-
ting (Figure 2), data were analysed as modified-intention-
to-treat. To account for cluster-randomised design, a ran-
dom effects logistic regression model was used to esti-
mate intervention effects and 95% confidence intervals; a
quadrature check performed to confirm model was a reli-
able fit to the data, and likelihood ratio test used to
assess statistical significance [13]. The analytical plan was
approved by an independent data safety and monitoring
board, prior to analysis. Data were double-entered and
verified using Microsoft Access 2007 (Microsoft Inc.,
Redmond, USA) and analysed using STATA version 12
(STATA Corporation, College Station, Texas, USA).
Ethical approval
This study was approved by the Uganda National Coun-
cil for Science and Technology and the London School of
Hygiene & Tropical Medicine Ethics Committee. Patients
refusing an mRDT test received presumptive treatment.
The study was registered with ClinicalTrials.gov. Identi-
fier NCT01048801 on 13 January 2010.
Results
To account for seasonal variations in malaria risk, data
were analysed for a 12-month period of routine implemen-
tation (January–December 2011), after the training and 6-
month period of close support supervision had ended.
During 2011, a total of 13 035 children were seen by
© 2016 The Authors. Tropical Medicine & International Health Published by John Wiley & Sons Ltd. 1161
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ELIGIBLE CLUSTERS: 63
RANDOMISED CLUSTERS: 63
CONTROL (PRESUMPTIVE)
RECEIVED TRAINING
Clusters: 32
CHWs: 96
CLUSTERS WITHDRAWN1
Clusters: 2
CHWs: 6
TOTAL CONSULTATIONS: 7320
Clusters: 30
CHWs: 90
BLOOD SLIDES COLLECTED: 7221
Clusters: 30
CHWs: 90
NO BLOOD SLIDE
Refused blood sample: 4 (0.1%)
No blood sample collected: 18 
INTERVENTION (mRDT)
RECEIVED TRAINING
Clusters: 31
CHWs: 93
CLUSTERS WITHDRAWN1
Clusters: 1
CHWs: 3
NO BLOOD SLIDE
Refused blood sample: 22 (0.3%)
No blood sample collected: 77
BLOOD SLIDES SAMPLED: 803
COMPLETE DATA: 699 (87.0%)
Clusters: 30
CHWs: 86
NO VALIDATION MICROSCOPY:
104 (13.0%) 
TOTAL CONSULTATIONS: 5715
Clusters: 30
CHWs: 90
BLOOD SLIDES COLLECTED: 5693
Clusters: 30
CHWs: 90
BLOOD SLIDES SAMPLED: 740
COMPLETE DATA: 656 (88.6%)
Clusters: 30
CHWs: 85
NO VALIDATION MICROSCOPY:
84 (11.4%) 
Figure 2 Trial profile, moderate-to-high transmission area.
1After training, CHWs in villages located close to the border of the study area started to receive febrile children from outside the study
district; these villages were subsequently withdrawn from the trial.
ELIGIBLE CLUSTERS: 64 
CONTROL (PRESUMPTIVE)
RECEIVED TRAINING
Clusters: 32
CHWs: 96
TOTAL CONSULTATIONS: 1768
Clusters: 32
CHWs: 96
BLOOD SLIDES COLLECTED: 1666
Clusters: 32
CHWs: 95
NO BLOOD SLIDE  
Refused blood sample :4 (0.4%)
No blood sample collected: 26 (3.0%)
INTERVENTION (mRDT)
RECEIVED TRAINING
Clusters: 32
CHWs: 96
NO BLOOD SLIDE 
Refused blood sample : 60 (3.4%) 
No blood sample collected: 42 (2.3%) 
TOTAL CONSULTATIONS: 908
Clusters: 32
CHWs: 92
BLOOD SLIDES COLLECTED: 877
Clusters: 32
CHWs: 92
COMPLETE DATA: 403 (46.0%) 
Clusters: 32
CHWs: 87
Treatment data missing: 10 (1.1%)
INCOMPLETE MICROSCOPY
1st reading missing/unreadable: 182 (10.9%)
2nd reading missing/unreadable: 431 (25.9%)
3rd reading missing/unreadable: 233 (14.0%)
COMPLETE DATA: 817 (49.0%)
Clusters: 32
CHWs: 90
Treatment data missing: 3 (0.2%)
INCOMPLETE MICROSCOPY
1st reading missing/unreadable: 109 (12.4%)
2nd reading missing/unreadable: 259 (29.5%)
3rd reading missing/unreadable: 96 (10.9%)
RANDOMISED CLUSTERS: 64
Figure 3 Trial profile, low transmission area.
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CHWs in 63 villages in Bwambara subcounty (the moder-
ate-to-high malaria transmission area), with 5715 children
seen by CHWs in the mRDT intervention arm and 7320
in the control arm (Figure 2). In Nyakashenyi subcounty
(the low transmission area), a total of 2676 children were
registered by CHWs in 64 villages during the same period:
908 and 1768 in mRDT and presumptive arm, respec-
tively (Figure 3). Most patients were willing to provide a
blood sample, in all study arms, with few refusals.
In both transmission settings, the number of consulta-
tions in the control arm usually exceeded those in the
mRDT arm, although the seasonal pattern was similar
across arms (Figure 4). In Bwambara subcounty, changes
in mRDT positivity mirrored changes in blood slide posi-
tivity. In Nyakashenyi subcounty, slide positivity was
generally <10%, but increased to 35.7% in August 2011;
mRDT positivity reached a peak of 9% in the same
month.
Effect of intervention on appropriately targeted
treatment: moderate-to-high transmission setting
Of the 12 914 blood slides collected by CHWs in
Bwambara subcounty, 1543 were sampled for validation
of the treatment decision by expert microscopy (Fig-
ure 2). Appropriately targeted treatment was evaluated
in patients for whom data on two or more independent
slide readings were available: 699 patients in the control
arm and 656 patients in the mRDT intervention arm,
comprising 87.0% and 88.6% of the slides sampled in
each arm, respectively. CHW and patient characteristics
were generally similar between the two arms (Table 2).
(a)  Bwambara sub-county, moderate-to-high malaria transmission setting
Intervention arm (mRDT)
(b)  Nyakishenyi sub-county, low transmission setting
Control arm (presumptive diagnosis)
Control arm (presumptive diagnosis)
Intervention arm (mRDT)
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Figure 4 Consultations for fever, malaria blood slide and rapid diagnostic test positivity by month in two areas of contrasting malaria
transmission intensity in south-western Uganda: January–December 2011. (a) Bwambara subcounty, moderate-to-high transmission
setting. (b) Nyakishenyi subcounty, low transmission setting.
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While over 80% of patients had sought treatment
within 24 h of onset of symptoms, there was greater
delay in the mRDT intervention villages than controls.
Slide positivity was also higher in the mRDT interven-
tion arm, 37.8% vs. 30.2% control (Table 3), with
37.6% of children in the intervention arm testing
mRDT positive. The sensitivity and specificity of mRDT
result against expert microscopy were 72.1% and
83.3%, respectively, with a positive predictive value
(PPV) of 72.4% and negative predictive value (NPV) of
83.1% in this area of moderate-to-high transmission
(Table 5).
Among febrile children seen by CHWs in the mRDT
intervention arm, 37.5% were treated with either
artemether–lumefantrine or rectal artesunate (hereafter
referred to collectively as ACT) compared with almost
100% of children seen by CHWs using presumptive diag-
nosis (Table 3). Only 16.4% of slide-negative children in
the mRDT intervention arm received an ACT, a signifi-
cant reduction in over-prescription compared with the
control arm, P < 0.001. Sixty-nine of the patients in the
mRDT intervention arm who did not receive ACT treat-
ment were slide positive, of whom 35 (51%) had parasite
densities ≤200 parasites per ll (Figure 5a). Use of
Table 2 Characteristics of clusters and community health workers in the intervention and control arms
Moderate-to-high transmission Low transmission
Control arm Intervention arm Control arm Intervention arm
Frequency (%) Frequency (%) Frequency (%) Frequency (%)
Number of participating villages 31 32 32 32
Total number of CHWs 90 90 96 96
CHWs characteristics*
Total CHWs interviewed 74 81 21 17
Age in years Median 39 40 41 40
Sex Male 24 (32.4) 26 (32.1) 6 (28.6) 2 (11.8)
Female 50 (67.6) 55 (67.9) 15 (71.4) 15 (88.2)
Highest level of school attendance Never 1 (1.6) 6 (6.4) 0 (0) 0 (0)
Primary 40 (64.5) 46 (59.0) 11 (52.4) 11 (64.7)
Secondary 20 (33.9) 21 (33.3) 10 (47.6) 6 (35.3)
Tertiary 0 (0) 1 (1.3) 0 (0) 0 (0)
CHW before Yes 47 (65.3) 39 (52.7) 14 (66.7) 7 (41.7)
No 25 (34.7) 35 (47.3) 7 (33.3) 10 (58.8)
Involvement in health activities before Yes 21 (30.0) 31 (45.6) 5 (26.3) 5 (31.3)
No 49 (68.1) 37 (50.0) 14 (66.7) 11 (64.7)
Elevation (metres above sea level) Mean (SD) 1131.21 (184.9) 1086.0 (53.7) 1829.8 (110.0) 1839.0 (120.9)
Patient characteristics†
Total number of children
seen by CHW
699 656 817 403
Age in years Mean (SD) 2.8 (1.5) 2.6 (1.4) 2.6 (1.4) 2.4 (1.5)
Sex Male 359 (51.7 335 (51.1) 434 (53.2) 198 (49.3)
Female 336 (48.3) 320 (48.9) 382 (46.8) 204 (50.7)
Slept under a mosquito
net the previous night
Yes 639 (92.7) 567 (87.4) 737 (91.1) 351 (87.8)
No 50 (7.3) 82 (12.6) 72 (8.9) 49 (12.3)
Resident in same village as CHW Yes 644 (92.5) 599 (91.6) 732 (89.8) 331 (82.5)
No 52 (7.5) 55 (8.4) 83 (10.2) 70 (17.5)
Time of presentation to
CHW after of onset of symptoms
Within 24 h 641 (93.4) 544 (84.6) 698 (88.8) 319 (80.2)
More than 24 h 45 (6.6) 99 (15.4) 88 (11.2) 79 (19.8)
*Data missing in moderate-to-high transmission setting, for highest level of school attendance: 21 (13 control, 8 intervention); previous
CHW status: 9 (2 control arm, 7 intervention); involvement in health activities before: 17 (4 control, 13 intervention). Data missing in
low transmission setting, for involvement in health activities before: 3 (2 control, 1 intervention).
†Data missing in moderate-to-high transmission setting, for age: 4 (2 control, 2 intervention); sex: 5 (4 control, 1 intervention); net
use: 17 (10 control, 7 intervention); resident in same village 5 (3 control, 2 intervention); onset of symptoms: 26 (13 control, 13 inter-
vention). Data missing in low transmission setting, for age: 14 (5 control, 9 intervention); sex: 2 (1 control, 1 intervention); net use: 11
(8 control, 3 intervention); resident in same village:4 (2 control, 2 intervention); onset of symptoms: 36 (31 control, 5 intervention).
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mRDTs was thus associated with a significant overall
improvement in the targeting of ACT treatments, such
that in this area of moderate-to-high transmission, 79.3%
of children in the mRDT arm received appropriately tar-
geted treatment compared with 30.8% in the control arm
(odds ratio 9.71, 95% CI 6.83–13.80; P < 0.001).
Despite greater delay in seeking treatment in the mRDT
arm, the proportion of children who received appropri-
ately targeted treatment within 24 h was also signifi-
cantly higher in the intervention arm (67.0% vs. 28.1%;
odds ratio 5.92, 95% CI 4.15–8.45; P < 0.001).
Effect of intervention on appropriately targeted
treatment: low transmission setting
A total of 2543 blood slides were collected by CHWs in
Nyakashenyi subcounty, of which two or more indepen-
dent slide readings were available for 49.0% and 47.1%
of slides in the control and mRDT arm, respectively
(Figure 3). Patient records missing treatment data were
few. Appropriately targeted treatment was thus evaluated
in the 817 and 403 patients with complete data in the
control and mRDT intervention arms, comprising 46.2%
and 44.4% of consultations in each arm, respectively.
Reasons for data loss included poor quality of the slides
prepared by CHWs and missing data on validation
microscopy. CHW and patient characteristics were simi-
lar between the two arms, although, as in the high trans-
mission area, there was slightly greater treatment delay in
mRDT intervention villages than controls; 80.2% vs.
88.8%, respectively, had sought treatment within 24 h of
onset of symptoms (Table 2). Slide positivity was 5.7%
overall, and similar in the two arms (Table 4), with
3.0% of children in the intervention arm reported to be
mRDT positive. The sensitivity of mRDT result against
microscopy was low (20.8%), and specificity was 98.1%
(Table 5). PPV in this low transmission setting was
41.7%, and NPV, 95.1%.
Table 3 Diagnosis and treatment of malaria by CHWs in Bwambara subcounty, January–December 2011: moderate-to-high transmis-
sion setting
Diagnosis and treatment
Control arm
31 clusters
Intervention arm
32 clusters
Frequency (%) Frequency (%)
Patients with complete data for primary endpoint 699 656
Blood slide positive 211 (30.2) 248 (37.8)
mRDT positive* n/a 243 (37.6)
Malaria treatment prescribed
Artemether-lumefantrine tablets (AL) 692 (99.0) 244 (37.2)
Rectal artesunate suppository 3 (0.4) 2 (0.3)
Neither AL nor rectal artesunate 4 (0.6) 410 (62.5)
Malaria treatment by infection status
Blood slide negative, received no ACT† 4 (0.8) 341 (83.4)
Blood slide negative, received ACT 484 (99.2) 67 (16.4)
Blood slide positive, received ACT 211 (100.0) 179 (72.2)
Blood slide positive, received no ACT 0 (0.0) 69 (27.8)
Trial endpoints n (%) n (%) Odds ratio (95% CI) P-value
Over-prescription
Proportion of blood slide negative patients
receiving ACT†
484 (99.2) 67 (16.4) 0.0013 (0.0004–0.0039) <0.001
Appropriately targeted treatment
Proportion of febrile patients receiving
appropriately targeted malaria treatment
with ACT
215 (30.8) 520 (79.3) 9.71 (6.83–13.80) <0.001
Prompt and appropriately targeted treatment
Proportion of febrile patients receiving
appropriately targeted treatment within
24 hours of onset of symptoms‡
195 (28.1) 433 (67.0) 5.92 (4.15–8.45) <0.001
*Ten patients missing RDT results.
†ACT defined as receiving either artemether-lumefantrine or rectal artesunate.
‡Fifteen missing data on time of treatment (five control, 10 intervention).
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When compared with malaria status by microscopy,
5.8% of slide-negative children in the mRDT intervention
arm received an ACT, a significant reduction in overpre-
scription compared with control arm, P = 0.002
(Table 4). However, of the 24 patients who were slide
positive, only 6 had received ACT treatment; 17 of the
18 that were untreated had parasite densities ≤200 para-
sites per ll (Figure 5b). Overall, use of mRDTs was
Table 4 Diagnosis and treatment of malaria by CHWs in Nyakishenyi subcounty, January–December 2011: low transmission setting
Diagnosis and treatment
Control arm
32 clusters
Intervention arm
32 clusters
Frequency (%) Frequency (%)
Patients with complete data for
primary endpoint
817 403
Blood slide positive 46 (5.6) 24 (6.0)
mRDT Positive* n/a 12 (3.0)
Malaria treatment prescribed
Artemether-lumefantrine tablets (AL) 773 (94.6) 22 (5.5)
Rectal artesunate suppository 18 (2.2) 6 (1.5)
Neither AL nor rectal artesunate 26 (3.2) 375 (93.1)
Malaria treatment by infection status
Blood slide negative, received no ACT† 22 (2.9) 357 (94.2)
Blood slide negative, received ACT 749 (97.2) 22 (5.8)
Blood slide positive, received ACT 42 (91.3) 6 (25.0)
Blood slide positive, received no ACT 4 (8.7) 18 (75.0)
Trial endpoints n (%) n (%) Odds ratio (95% CI) P-value
Over-prescription
Proportion of blood slide negative
patients receiving ACT
749 (97.2) 22 (5.8) 0.00022 (0.00004–0.00125) 0.002
Appropriately targeted treatment
Proportion of febrile patients receiving
appropriately targeted malaria treatment
with ACT
64 (7.8) 363 (90.1) 162.9 (83.0 – 319.6) <0.001
Prompt and appropriately targeted treatment
Proportion of febrile patients receiving
appropriately targeted treatment within
24 hours of onset of symptoms‡
49 (6.0) 287 (72.1) 40.3 (28.1 - 57.9) <0.001
*One patient missing mRDT result.
†ACT defined as receiving either artemether-lumefantrine or rectal artesunate.
‡Nine missing data on time of treatment (four control, five intervention).
Table 5 Sensitivity and specificity of malaria rapid diagnostic tests (mRDTs) performed by community health workers in two areas of
contrasting transmission intensity
Result reported by CHW*
Moderate-to-high transmission setting Low transmission setting
Expert microscopy†
Predictive value
of mRDT, %
Expert microscopy†
Predictive value
of mRDT, %Positive (%) Negative (%) Positive (%) Negative (%)
mRDT positive 176 (72.1) 67 (16.7) 72.4 5 (20.8) 7 (1.9) 41.7
mRDT negative 68 (27.9) 335 (88.3) 83.1 19 (79.2) 371 (98.1) 95.1
Total samples examined 244 402 24 378
*Missing data on RDT result: 10 in high transmission setting; 1 in low transmission setting.
†Result of blood slides double-read by two independent microscopists, with discrepant findings resolved by a third independent reader;
all blind to RDT result.
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associated with a dramatic improvement in the targeting
of ACT treatments; 94.2% of children in the mRDT
intervention arm received appropriately targeted treat-
ment compared with 25.0% on the control arm (odds
ratio 162.9, 95% CI 83.0–319.6; P < 0.001). The pro-
portion of children who received appropriately targeted
treatment within 24 h was also significantly higher in the
intervention arm (72.1% vs. 6.0%, P < 0.001).
Discussion
This study confirms that use of mRDTs by CHWs can
reduce the number of ACTs used, as documented in
previous studies [10, 14, 15], and additionally demon-
strates that mRDTs can substantially improve the target-
ing of ACT treatment to children with malaria in
community-based treatment programmes. With use of
mRDT-based diagnosis, the proportion of children receiv-
ing appropriately targeted ACT treatment from CHWs
(consistent with their true malaria infection status as
determined by later expert microscopy) exceeded 80% in
both transmission settings; a significant increase over pre-
sumptive treatment (P < 0.001 in both sites). The effect
was more marked in the low transmission area where
more than 90% of the patients received appropriately tar-
geted treatment in the mRDT arm. This could be attribu-
table to the combination of high specificity of mRDT in a
setting of low and unstable malaria transmission, where
nearly 100% of mRDT negatives were negative by light
microscopy, and high adherence to mRDT results by
CHWs. In contrast, where CHWs followed presumptive
diagnosis, more than 90% of patients subsequently found
to be slide negative had received an unnecessary ACT
treatment. This concurs with previous reports that over-
use of ACTs is likely to be higher in areas with low
malaria prevalence [16, 17]. A high degree of adherence
to test results by CHWs has frequently been observed in
studies among CHWs, in contrast to the less favourable
reports from research among health facility-based provi-
ders and some other community programmes [18–23].
Factors which may have contributed to high adherence in
our trial were the comprehensive and participatory train-
ing that CHWs received, including clear guidance on
referral criteria and how to handle RDT-negative
patients, and community meetings to create awareness
that not all fevers are due to malaria and explain the
rationale for diagnostic testing at community level. Fur-
thermore, the use of job aids, previously found to be an
important aid for CHWs to interpret and adhere to
mRDT results [23], and supportive supervision during the
immediate post-training period, may have sustained the
awareness and adherence to guidelines [24] and enhanced
CHWs self-esteem and confidence in what they were
doing. Educative interaction between caretakers and
health workers has been shown to be a major factor for
community acceptability of RDT use [25]. Close proxim-
ity of CHWs to other members of the community, cou-
pled with community sensitisation and the
communication training provided to CHWs as part of the
intervention, may also have facilitated high adherence to
mRDT results by CHWs.
More than 80% of patients with fever in the interven-
tion and control arms in both transmission settings con-
sulted CHWs for treatment within 24 h after onset of
symptoms, which is much higher than has previously
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Figure 5 Rapid diagnostic test results performed and read by
community health workers in relation to parasite density mea-
sured by expert light microscopy (Data are shown for children
with parasites detected in a thick blood film). (a) Moderate-to-
high transmission area. (b) Low transmission area.
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been observed at health facilities in Uganda [11] and else-
where [26]. These data show that CHWs provide an
opportunity for improving the speed of treatment seeking
for febrile illnesses in rural areas, where poor access to
health facilities, lack of drugs, perceived high cost and
unfriendly attitude of health workers often result in
delayed treatment [27–32] and illustrate the role of com-
munity-based treatment programmes in increasing access
to prompt effective treatment of malaria.
The sensitivity of mRDTs in this study was lower than
has been previously observed among CHWs [23], particu-
larly in the low malaria area, which could be due to the
large proportion of low parasite density infections
observed in those patients who were untreated, and
which may therefore have been undetected by mRDT
[33, 34]. Blood slides were prepared by CHWs, which
was found to be a particular limitation in our study and
others [14], and reduced the number of samples exam-
ined by microscopy and thus available for analysis, espe-
cially in the low transmission area. Nonetheless, the
characteristics of patients included in the final analysis
and CHWs were comparable between arms and we do
not consider our findings could be attributed to selection
bias. The mRDTs used passed independent quality-assur-
ance batch testing, and we can confidently exclude test
performance as a reason for low sensitivity. As the major-
ity of false negatives were low-density infections, we can
also exclude the possibility that this was due to a prozone
effect; though the frequency of HRP-2 deletions in this
population is unknown [35]. Other possible causes for
false-negative mRDT results include operator error, espe-
cially where a CHW works under poor lighting condi-
tions and/or at night [35]. Nonetheless, as missed
treatment was frequently observed in low-density infec-
tion, below the acknowledged limit of detection of most
mRDTs, we consider this to be the most likely cause for
this observation. False positives were higher in the high
transmission area than in the low transmission area, as
would be expected due to persistent antigenaemia in indi-
viduals recently infected by malaria in hyperendemic
areas [36].
The benefits of using mRDTs to improve targeting of
ACTs and limit their overuse need to be weighed against
the risks of not treating an infected child [37]. Among
semi-immune children with low parasite counts in the
moderate-to-high transmission area, the probability that
the fever is attributable to malaria is low [38, 39], and
antimalarial treatment is not necessarily required. How-
ever, missed treatment in non-immune subjects in the low
transmission area is of greater potential concern. A limi-
tation of this study was that we did not follow up
patients to see if they recovered so we do not know the
clinical outcome in those who missed receiving treatment
when they were mRDT negative but proved to be
parasite-positive on microscopy. Poor sensitivity of HRP-
2-based mRDTs has previously been reported from other
areas of low transmission [33, 34], and more sensitive
point-of-care diagnostic techniques, of low cost and suit-
able for routine use in these low transmission settings,
are needed. Thus, before scaling up mRDT use by CHWs
in low transmission areas, we would suggest that safety
studies with follow-up data on patients who missed treat-
ment due low sensitivity of current mRDTs be conducted
to adequately assess the risk of non-treatment of low-den-
sity infections in non-immunes. It is conceivable that
missed treatments are more frequent in community-based
programmes than in other health services using mRDTs,
as patients may be more likely to seek care at an earlier
stage in their illness. Parasite density among patients pre-
senting to CHWs may therefore be lower than in patients
who first present to health facilities, and a greater pro-
portion of them may have an infection below the detec-
tion threshold of current mRDTs, irrespective of local
transmission intensity. Encouraging patients with no
symptoms other than fever, who test mRDT negative, to
return to the CHW for re-evaluation and retesting
whether symptoms do not improve, could help mitigate
the risk of not treating an infected child.
Conclusion
The findings presented here underscore the value of
mRDT-based diagnosis of malaria in reducing overuse of
ACTs in community case management and should be of
particular interest to malaria programme managers and
policymakers, nationally, regionally and internationally
as countries scale up iCCM [40]. Equipping CHWs with
mRDTs markedly improved the appropriate targeting of
ACT treatment. With increased financing for malaria and
large-scale control, the prevalence of malaria should
reduce and the potential role of mRDTs in targeting
malaria treatment and disease surveillance will become
ever more critical [41] at all levels of health service deliv-
ery, including community level. Use of mRDTs and diag-
nostic algorithms has the additional potential to also
improve detection and treatment of non-malaria fevers.
Our data show mRDT use was beneficial in improving
the targeting of ACT use in both moderate-to-high and
low transmission areas and that a widespread adoption
of mRDTs at community level can reduce misdiagnosis
and inappropriate treatment of febrile illness in all
malaria transmission settings. Nonetheless, mRDTs have
several limitations that may reduce their utility in low
transmission settings because they do not reliably detect
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low-density parasitaemia. Studies have shown that in
infants, parasitaemia is synonymous to clinical malaria
[42]. Therefore, missed treatments due to the low sensi-
tivity of current mRDTs to low-density infections (as
reported here and in other areas of low transmission
[34]) are a concern and suggest that despite the potential
cost savings from reduced use of ACTs, presumptive
diagnosis and treatment of all fevers as malaria may
remain advisable in malarious areas where populations
have little or no immunity, until such time as more sensi-
tive diagnostic assays become widely available.
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